Skip to main content

Table 3 RP Grade and incidence of acute exacerbation

From: Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis

RP grade (CTCAE ver3.0)

 1

9 (31%)

 2

12 (41%)

 3

8 (28%)

RP grade progression after treatment

 0/1/2

24/4/1

Acute exacerbation

2 (7%)a

RP symptom onset time

 

 no symptom

15 (52%)

 0–3 month

9 (31%)

 3–6 month

5 (17%)

  1. aThese patients are also included in RP grade 3 data
  2. Abbreviations: CTCAE Common Terminology Criteria for Adverse Events, RP radiation pneumonitis